255 — Lung Kee group Cashflow Statement
0.000.00%
- HK$1.14bn
- HK$625.13m
- HK$1.55bn
- 95
- 64
- 61
- 89
Annual cashflow statement for Lung Kee group, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 221 | 315 | 21.7 | -113 | -19.4 |
| Depreciation | |||||
| Non-Cash Items | -0.786 | -11 | -33.7 | -6.14 | -3.63 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -11.4 | -107 | -69.8 | 26.9 | 81.7 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 355 | 354 | 76.9 | 77.2 | 226 |
| Capital Expenditures | -113 | -201 | -182 | -113 | -35.5 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 18.9 | 24.5 | 24.6 | 14.9 | 11.2 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -94.2 | -177 | -158 | -98.1 | -24.4 |
| Financing Cash Flow Items | -0.509 | -0.455 | -0.363 | -0.406 | -0.281 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -139 | -278 | -169 | -73.9 | -67.3 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 165 | -85 | -297 | -108 | 118 |